Hims & Hers Health Operating Expenses 2020-2025 | HIMS
Hims & Hers Health annual/quarterly operating expenses history and growth rate from 2020 to 2025. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Hims & Hers Health operating expenses for the quarter ending March 31, 2025 were $0.528B, a 96.86% increase year-over-year.
- Hims & Hers Health operating expenses for the twelve months ending March 31, 2025 were $1.674B, a 73.04% increase year-over-year.
- Hims & Hers Health annual operating expenses for 2024 were $1.415B, a 56.93% increase from 2023.
- Hims & Hers Health annual operating expenses for 2023 were $0.901B, a 51.35% increase from 2022.
- Hims & Hers Health annual operating expenses for 2022 were $0.596B, a 53.94% increase from 2021.
| Hims & Hers Health Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2024 | $1,415 |
| 2023 | $901 |
| 2022 | $596 |
| 2021 | $387 |
| 2020 | $164 |
| 2019 | $157 |
| 2018 | $0 |
| Hims & Hers Health Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $528 |
| 2024-12-31 | $463 |
| 2024-09-30 | $379 |
| 2024-06-30 | $305 |
| 2024-03-31 | $268 |
| 2023-12-31 | $247 |
| 2023-09-30 | $235 |
| 2023-06-30 | $217 |
| 2023-03-31 | $202 |
| 2022-12-31 | $179 |
| 2022-09-30 | $165 |
| 2022-06-30 | $134 |
| 2022-03-31 | $118 |
| 2021-12-31 | $106 |
| 2021-09-30 | $102 |
| 2021-06-30 | $78 |
| 2021-03-31 | $101 |
| 2020-12-31 | $46 |
| 2020-09-30 | $45 |
| 2020-06-30 | $37 |
| 2020-03-31 | $36 |
| 2019-12-31 | |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $11.606B | $1.477B |
| Hims & Hers Health Inc. is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling medical care for numerous conditions related to mental health, sexual health, dermatology, primary care and more. Hims & Hers Health Inc., formerly known as Oaktree Acquisition Corp., is based in San Francisco. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.159B | 58.73 |
| Doximity (DOCS) | United States | $11.724B | 54.28 |
| Tempus AI (TEM) | United States | $10.382B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.374B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.760B | 58.76 |
| Hinge Health (HNGE) | United States | $3.663B | 0.00 |
| Privia Health (PRVA) | United States | $2.509B | 171.50 |
| Enovis (ENOV) | United States | $1.745B | 9.73 |
| Phreesia (PHR) | United States | $1.609B | 0.00 |
| Schrodinger (SDGR) | United States | $1.559B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.537B | 0.00 |
| 10x Genomics (TXG) | United States | $1.523B | 0.00 |
| Azenta (AZTA) | United States | $1.469B | 68.25 |
| Evolent Health (EVH) | United States | $1.343B | 114.40 |
| Omnicell (OMCL) | United States | $1.301B | 22.96 |
| Claritev (CTEV) | United States | $0.725B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.549B | 0.00 |
| Veradigm (MDRX) | United States | $0.499B | 0.00 |
| Standard BioTools (LAB) | United States | $0.471B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.443B | 0.00 |
| Talkspace (TALK) | United States | $0.416B | 124.25 |
| TruBridge (TBRG) | United States | $0.326B | 722.33 |
| Outset Medical (OM) | United States | $0.321B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.271B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.264B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.241B | 0.00 |
| CapsoVision (CV) | United States | $0.221B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.188B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.144B | 0.00 |
| American Well (AMWL) | United States | $0.129B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.121B | 0.00 |
| Pulmonx (LUNG) | United States | $0.117B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.104B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.87 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.088B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| 111 (YI) | China | $0.065B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.047B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.028B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |